|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 9/64 | (2006.01) |
| C07K 14/755 | (2013.01) | ||
| C07K2319/00 | (2013.01) | ||
| A61K 38/00 | (2013.01) |
| (11) | Number of the document | 3775194 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19717186.1 |
| Date of filing the European patent application | 2019-04-11 | |
| (97) | Date of publication of the European application | 2021-02-17 |
| (45) | Date of publication and mention of the grant of the patent | 2023-06-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2019/059233 |
| Date | 2019-04-11 |
| (87) | Number | WO 2019/197524 |
| Date | 2019-10-17 |
| (30) | Number | Date | Country code |
| 18166982 | 2018-04-12 | EP |
| (72) |
WINTERLING, Karina , DE
KISTNER, Steffen , DE
DAUFENBACH, Jens , DE
DE GROOT, Annie , US
MARTIN, William , US
UNGERER, Christopher , DE
|
| (73) |
Biotest AG ,
Landsteinerstr. 5, 63303 Dreieich,
DE
|
| (54) | DE-IMMUNIZED FACTOR VIII MOLECULE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME |
| DE-IMMUNIZED FACTOR VIII MOLECULE AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME |